A 47-year old male, Kishore exhibited signs and symptoms of acromegaly. Radiologic studies showed the presence of a large pituitary tumor. Surgical treatment of the tumor was only partially effective in controlling the disease. At this point, which of the following drugs is most likely to be used as pharmacological therapy?

**Core Concept**
Acromegaly is a disorder caused by excess growth hormone (GH) production, often resulting from a pituitary adenoma. Pharmacological therapy is used to control GH secretion in cases where surgical treatment is ineffective.

**Why the Correct Answer is Right**
Somatostatin analogs, such as octreotide, are used to treat acromegaly by inhibiting the secretion of GH from the pituitary gland. These drugs work by binding to somatostatin receptors on the surface of pituitary cells, which decreases the production and release of GH. This leads to a decrease in insulin-like growth factor 1 (IGF-1) levels, a marker of GH activity.

**Why Each Wrong Option is Incorrect**
* **Option A:** Bromocriptine is a dopamine agonist used to treat prolactinomas, not acromegaly.
* **Option B:** Cabergoline is also a dopamine agonist primarily used for prolactinomas and some cases of hyperprolactinemia.
* **Option D:** Pegvisomant is a GH receptor antagonist, but it is typically used as a second-line treatment after somatostatin analogs have failed.

**Clinical Pearl / High-Yield Fact**
Somatostatin analogs can cause gastrointestinal side effects such as diarrhea and abdominal pain due to their effect on the release of other hormones, including gastrin and secretin.

**Correct Answer:** D. Pegvisomant is not the most likely choice here, however, based on the options given, we can deduce that the correct answer is **C.**

✓ Correct Answer: C. Octreotide